Intellectual Property: Valuation, Exploitation and Infringement Damages 2013 Cumulative Supplement, 11th Edition

Book description

Designed to simplify the process of attaching a dollar amount to intangible assets, Intellectual Property Valuation, Exploitation and Infringement Damages 2013 Cumulative Supplement provides practical tools for evaluating the investment aspects of licensing and joint venture decisions. It discusses the legal, tax, and accounting practices and procedures related to such arrangements and examines the business economics of strategies involving intellectual property licensing and joint ventures. Licensing professionals are provided analytical models to determine reasonable royalty rates for licensing and for determining fair equity splits in joint venture arrangements.

Table of contents

  1. Cover Page
  2. Title Page
  3. Copyright
  4. ABOUT THE AUTHORS
  5. ABOUT THE CONTRIBUTORS
  6. CONTENTS
  7. PREFACE
  8. PART 1: VALUATION
    1. CHAPTER 1A: INTELLECTUAL PROPERTY LANDSCAPE (NEW)
      1. 1A.1 80% OF CORPORATE VALUE IS INTELLECTUAL PROPERTY AND INTANGIBLE ASSETS
      2. 1A.2 OVER SEVEN MILLION PATENTS
      3. 1A.3 CORPORATIONS OWN THE MOST PATENTS
      4. 1A.4 ALL INDUSTRIES ARE PATENTING INVENTIONS
      5. 1A.5 TRADEMARKS
      6. 1A.6 TRADEMARKS ARE SUPPORTED WITH HUGE AD SPENDING
      7. 1A.7 COPYRIGHTS
      8. 1A.8 TRADE SECRETS
      9. 1A.9 BUSINESS OF LICENSING
    2. CHAPTER 1B: U.S. CONGRESS FLIRTS WITH DISASTER (NEW)
      1. 1B.1 PATENT LITIGATION VENUE
      2. 1B.2 PATENT INFRINGEMENT DAMAGES
      3. 1B.3 INJUNCTIONS FOR ONLY COMPETITORS
      4. 1B.4 HARMING OUR ONLY ECONOMIC ADVANTAGE
    3. CHAPTER 12A: RISK-ADJUSTED CASH FLOWS (NEW)
      1. 12A.1 REQUIRED RATES OF RETURN
      2. 12A.2 CAPITAL ASSET PRICING MODEL
      3. 12A.3 BUILD-UP METHOD
      4. 12A.4 VENTURE CAPITAL RATES OF RETURN
      5. 12A.5 PROBABILITY OF SUCCESS
      6. 12A.6 CONCLUSION
    4. CHAPTER 12B: DEALING WITH RISK AND UNCERTAINTY IN INTELLECTUAL PROPERTY VALUATION AND EXPLOITATION (NEW)
      1. 12B.1 RISK VERSUS UNCERTAINTY
      2. 12B.2 DECISION ANALYSIS AND DECISION TREES
      3. 12B.3 DECISION TREE COMPONENTS AND CONVENTIONS
      4. 12B.4 MONTE CARLO TECHNIQUES 26
      5. 12B.5 MARKOV CHAINS
      6. 12B.6 OBTAINING INFORMATION FROM INDIRECT OBSERVATION: SHADOW PRICING
      7. 12B.7 BAYESIAN ANALYSIS
      8. 12B.8 OPTION PRICING MODELS
      9. 12B.9 LIMITATIONS ON RATIONALITY IN DECISION MAKING: THE EFFECTS OF PERCEPTION AND BIASES ON DECISION MAKING
      10. 12B.10 CONCLUSION
    5. CHAPTER 14A: RIGHTS OF PRIVACY, PUBLICITY, AND CELEBRITY PERSONA (NEW)
      1. 14A.1 INTRODUCTION
      2. 14A.2 LEGAL UNDERPINNINGS
      3. 14A.3 TRADEMARK RIGHTS
      4. 14A.4 COPYRIGHT
      5. 14A.5 LEGAL UNCERTAINTIES AND SOLUTIONS
      6. 14A.6 A PHOTOGRAPHY ISSUE
      7. 14A.7 CONCLUSION
    6. CHAPTER 14B: INTELLECTUAL PROPERTY AND INTANGIBLE ASSET VOLATILITY (NEW)
  9. PART 2: LICENSING
    1. CHAPTER 27A: ROYALTY RATES AND LICENSE FEES FOR TECHNOLOGY (NEW)
      1. 27A.1 ROYALTY RATES
      2. 27A.2 PER UNIT ROYALTIES
      3. 27A.3 ROYALTIES BASED ON PROFITABILITY
      4. 27A.4 LICENSE FEES
      5. 27A.5 MEDICAL DEVICE INDUSTRY ROYALTY RATES
      6. 27A.6 MEDICAL DEVICE INDUSTRY LICENSE FEE DISTRIBUTION
      7. 27A.7 CONCLUSION
    2. CHAPTER 27B: * LICENSE FEES AND ROYALTY RATE FREQUENCY FOR TECHNOLOGY (NEW)
      1. 27B.1 REAL DEAL ROYALTY RATES
      2. 27B.2 PER UNIT ROYALTIES
      3. 27B.3 LICENSE FEES
      4. 27B.4 CONCLUSION
    3. CHAPTER 27C: * ROYALTY RATES AND LICENSE FEES FOR PHARMACEUTICALS AND BIOTECHNOLOGY (NEW)
      1. 27C.1 THE PARTIES—LICENSING BETWEEN CORPORATIONS DOMINATES
      2. 27C.2 ROYALTY RATES
      3. 27C.3 LICENSE FEES
      4. 27C.4 KEY TECHNOLOGIES
      5. 27C.5 DEVELOPMENTAL STAGES OF TECHNOLOGY
      6. 27C.6 CONCLUSION
    4. CHAPTER 33A: THE MAGNITUDE AND MEANING OF ROYALTY MISREPORTING (NEW)
      1. 33A.1 INTRODUCTION
      2. 33A.2 “WHY?” VERSUS “HOW?”
      3. 33A.3 MATH ERRORS: 5% ERROR RATE
      4. 33A.4 ROYALTY RATE ERRORS: 4% ERROR RATE
      5. 33A.5 TRANSFER PRICES: 4% ERROR RATE
      6. 33A.6 UNREPORTED BENCHMARKS AND MILESTONES: 5% ERROR RATE
      7. 33A.7 UNREPORTED SALES: 16% ERROR RATE
      8. 33A.8 DISALLOWED DEDUCTIONS: 9% ERROR RATE
      9. 33A.9 UNREPORTED SUBLICENSES: 17% ERROR RATE
      10. 33A.10 QUESTIONABLE LICENSE INTERPRETATION: 40% ERROR RATE
      11. 33A.11 CONCLUSION
    5. CHAPTER 33B: INTELLECTUAL PROPERTY AUDIT AND MANAGEMENT (NEW)
      1. 33B.1 INTRODUCTION
      2. 33B.2 INTELLECTUAL PROPERTY IS IMPORTANT
      3. 33B.3 BUT INTELLECTUAL PROPERTY IS FREQUENTLY MISMANAGED
      4. 33B.4 WHY THE INTELLECTUAL PROPERTY DICHOTOMY?
      5. 33B.5 THE FIRST STEP: AN INTELLECTUAL PROPERTY AUDIT
      6. 33B.6 FROM IP AUDIT TO IP MANAGEMENT
      7. 33B.7 INSUFFICIENT APPROACHES
      8. 33B.8 A NEW INTELLECTUAL PROPERTY MANAGEMENT PARADIGM
      9. 33B.9 AVAILABLE TOOLS
      10. 33B.10 BENEFITS OF INTELLECTUAL PROPERTY MANAGEMENT
      11. 33B.11 WHEN TO DO AN INTELLECTUAL PROPERTY AUDIT
      12. 33B.12 HOW TO DO AN INTELLECTUAL PROPERTY AUDIT
      13. 33B.13 SOFTWARE SOLUTIONS TO MAKE THE JOB EASIER
      14. 33B.14 CONCLUSION
    6. CHAPTER 35A: QUANTIFYING REASONABLE ROYALTIES: THE ENTIRE MARKET VALUE RULE (NEW)
    7. CHAPTER 45: NEW MEASURE OF INFRINGEMENT DAMAGES—FUTURE DAMAGES (NEW)
      1. 45.1 ROYALTY RATE FOR FUTURE DAMAGES
      2. 45.2 WHAT ABOUT FUTURE LOST PROFITS?
    8. CHAPTER 45A: CONTINUALLY EVOLVING PATENT DAMAGES (NEW)
      1. 45A.1 POST-VERDICT ROYALTY RATES
      2. 45A.2 OPTIMIZE YOUR PATENTED TECHNOLOGY OR LOSE IT
      3. 45A.3 LITIGATION-BASED LICENSES
    9. CHAPTER 45B: * THE 25% RULE IS DEAD (NEW)
  10. APPENDIX G: MORE SAMPLE ROYALTY RATE INFORMATION (NEW)
  11. APPENDIX H: TRADEMARK ROYALTY RATES (NEW)
  12. APPENDIX I: PHARMACEUTICAL AND BIOTECHNOLOGY ROYALTY RATES (NEW)
  13. APPENDIX J: * TELECOMMUNICATIONS ROYALTY RATES (NEW)
  14. APPENDIX K: * ELECTRICAL AND ENERGY ROYALTY RATES (NEW)
  15. INDEX

Product information

  • Title: Intellectual Property: Valuation, Exploitation and Infringement Damages 2013 Cumulative Supplement, 11th Edition
  • Author(s): Russell L. Parr
  • Release date: April 2013
  • Publisher(s): Wiley
  • ISBN: 9781118363065